The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer
Open accessAbstract
Purpose: It is unknown whether irradiation of the internal mammary lymph nodes improves survival in patients with early-stage breast cancer. A possible survival benefit might be offset by radiation-induced heart disease. We assessed the effect of internal mammary node irradiation (IMNI) in patients with early-stage node-positive breast cancer. Patients and Methods: In this nationwide, prospective population-based cohort study, we included patients who underwent operation for unilateral early-stage node-positive breast cancer. Patients with right-sided disease were allocated to IMNI, whereas patients with left-sided disease were allocated to no IMNI because of the risk of radiation-induced heart disease. The primary end point was overall survival. Secondary end points were breast cancer mortality and distant recurrence. Analyses were by intention to treat. Results: A total of 3,089 patients were included. Of these, 1,492 patients were allocated to IMNI, whereas 1,597 patients were allocated to no IMNI. With a median of 8.9 years of follow-up time, the 8-year overall survival rates were 75.9% with IMNI versus 72.2% without IMNI. The adjusted hazard ratio (HR) for death was 0.82 (95% CI, 0.72 to 0.94; P = .005). Breast cancer mortality was 20.9% with IMNI versus 23.4% without IMNI (adjusted HR, 0.85; 95% CI, 0.73 to 0.98; P = .03). The risk of distant recurrence at 8 years was 27.4% with IMNI versus 29.7% without IMNI (adjusted HR, 0.89; 95% CI, 0.78 to 1.01; P = .07). The effect of IMNI was more pronounced in patients at high risk of internal mammary node metastasis. Equal numbers in each group died of ischemic heart disease. Conclusion: In this naturally allocated, population-based cohort study, IMNI increased overall survival in patients with early-stage node-positive breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Darby, S. C., Ewertz, M., McGale, P., Bennet, A. M., Blom-Goldman, U., Brønnum, D., Correa, C., Cutter, D., Gagliardi, G., Gigante, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209825 · Cited by 3,974 · cited 1×
“The rate of major coronary events, including ischemic heart death, has been found to be dependent on the mean heart dose.(23) The negative effect of cardiac irradiation may be aggravated by the addition of chemotherapy, which was used in greater than half of our patients.”
BackgroundOvergaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Self-citationEBCTCG (Early Breast Cancer Trialists' Collaborative Group) (2014) · The Lancet · doi:10.1016/s0140-6736(14)60488-8 · Cited by 2,254
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
Ragaz, J., Jackson, S. M., Le, N., Plenderleith, I. H., Spinelli, J. J., Basco, V. E., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Paradis, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371402 · Cited by 1,745
Overgaard, M., Jensen, M.-B., Overgaard, J., Hansen, P. S., Rose, C., Andersson, M., Kamby, C., Kjaer, M., Gadeberg, C. C., Rasmussen, B. B., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09201-0 · Cited by 1,602
Self-citationRegional Nodal Irradiation in Early-Stage Breast Cancer
Whelan, T. J., Olivotto, I. A., Parulekar, W. R., Ackerman, I., Chua, B. H., Nabid, A., Vallis, K. A., White, J. R., Rousseau, P., Fortin, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415340 · Cited by 1,294
Darby, S. C., McGale, P., Taylor, C. W., & Peto, R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70251-5 · Cited by 1,049
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
Poortmans, P. M., Collette, S., Kirkove, C., Van Limbergen, E., Budach, V., Struikmans, H., Collette, L., Fourquet, A., Maingon, P., Valli, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415369 · Cited by 1,005
Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer
Hooning, M. J., Botma, A., Aleman, B. M. P., Baaijens, M. H. A., Bartelink, H., Klijn, J. G. M., Taylor, C. W., & van Leeuwen, F. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk064 · Cited by 861
McGale, P., Darby, S. C., Hall, P., Adolfsson, J., Bengtsson, N.-O., Bennet, A. M., Fornander, T., Gigante, B., Jensen, M.-B., Peto, R., et al. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.06.016 · Cited by 459
Højris, I., Overgaard, M., Christensen, J. J., & Overgaard, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02245-x · Cited by 350
Self-citationMøller, S., Jensen, M.-B., Ejlertsen, B., Bjerre, K. D., Larsen, M., Hansen, H. B., Christiansen, P., & Mouridsen, H. T. (2008) · Acta Oncologica · doi:10.1080/02841860802059259 · Cited by 273
Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients.
Shapiro, C. L., Hardenbergh, P. H., Gelman, R., Blanks, D., Hauptman, P., Recht, A., Hayes, D. F., Harris, J., & Henderson, I. C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3493 · Cited by 264
Grantzau, T., & Overgaard, J. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.10.004 · Cited by 207
Self-citationMannino, M., & Yarnold, J. R. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.05.002 · Cited by 138
Ejlertsen, B., Jensen, M., Rank, F. E., Rasmussen, B., Christiansen, P., Kroman, N. T., Kvistgaard, M. E., Overgaard, M., Toftdahl, D. B., & Mouridsen, H. T. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp090 · Cited by 112
Self-citationThorsen, L. B. J., Thomsen, M. S., Berg, M., Jensen, I., Josipović, M., Overgaard, M., Overgaard, J., Skogholt, P., & Offersen, B. V. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.925579 · Cited by 84
Self-citationOvergaard, M., & Christensen, J. J. (2008) · Acta Oncologica · doi:10.1080/02841860802078085 · Cited by 42
Self-citationTramm, T., Kyndi, M., Myhre, S., Nord, S., Alsner, J., Sørensen, F. B., Sørlie, T., & Overgaard, J. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.925580 · Cited by 35
Self-citationOlson, R. A., Woods, R. R., Speers, C. H., Lau, J., Lo, A., Truong, P. T., Tyldesley, S. K., Olivotto, I. A., & Weir, L. M. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.11.066 · Cited by 34
Cited by
Harbeck, N., Penault-Llorca, F., Cortes, J., Gnant, M., Houssami, N., Poortmans, P., Ruddy, K., Tsang, J., & Cardoso, F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0111-2 · Cited by 3,024
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Recht, A., Comen, E. A., Fine, R. E., Fleming, G. F., Hardenbergh, P. H., Ho, A. Y., Hudis, C. A., Hwang, E. S., Kirshner, J. J., Morrow, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1188 · Cited by 340
Metadata
- Authors
- Thorsen, L. B. J., Offersen, B. V., Danø, H., Berg, M., Jensen, I., Pedersen, A. N., Zimmermann, S. J., Brodersen, H.-J., Overgaard, M., & Overgaard, J.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-02-01
- Volume
- 34
- Issue
- 4
- Pages
- 314-320
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2176010689
- Cited by
- 426
- References
- 22
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.